Milk Peptides and Immune Response in the Neonate

  • Ioannis Politis
  • Roubini Chronopoulou
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 606)

Abstract

Bioactive peptides encrypted within the native milk proteins can be released by enzymatic proteolysis, food processing, or gastrointestinal digestion. These peptides possess a wide range of properties, including immunomodulatory properties. The first months of life represent a critical period for the maturation of the immune system because a tolerance for nutrient molecules should be developed while that for pathogen-derived antigens is avoided. Evidence has accumulated to suggest that milk peptides may regulate gastrointestinal immunity, guiding the local immune system until it develops its full functionality. Our data using the weaning piglet as the model suggest that several milk peptides can downregulate various immune properties at a time (one to two weeks after weaning) that coincides with immaturity of the immune system. The protein kinase A system and/or the exchange protein directly activated by cyclic AMP (Epac-1) are implicated in the mechanism through which milk peptides can affect immune function in the early postweaning period. Despite the fact that the research in this field is in its infancy, the evidence available suggests that milk protein peptides may promote development of neonatal immune competence.

Milk contains a variety of components that provide immunological protection and facilitate the development of neonatal immune competence. Two main categories of milk compounds are thought to be associated with immunological activity. The first category includes cytokines, which neonates do not produce efficiently. Cytokines present in milk are thought to be protected against intestinal proteolysis and could alleviate immunological deficits, aiding immune system maturation (Kelleher&Lonnerdal, 2001; Bryan et al., 2006). The second category of milk compounds includes milk protein peptides. Milk peptides may affect mucosal immunity possibly by guiding local immunity until it develops its full functionality (Baldi et al., 2005). This chapter focuses on the effects of milk peptides on immune function and attempts to provide an overview of the knowledge available in this field.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aronoff, D. M., Canetti, C., & Peters-Golden, M. (2004). Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. Journal of Immunology, 173, 559–563.Google Scholar
  2. Bailey, M., Clarke, C. J., Wilson, A. D., Williams, N. A., & Stokes, C. R. (1992). Depressed potential for interleukin-2 production following early weaning of piglets. Veterinary Immunology and Immunopathology, 34, 197–207.CrossRefGoogle Scholar
  3. Bailey, M., Haverson, K., Inman, C., Harris, C., Jones, P., Corfield, G., Miller, B., & Stokes, C. (2005). The development of the mucosal immune system pre- and post-weaning: Balancing regulatory and effector function. Proceedings of Nutritional Society, 64, 451–457.CrossRefGoogle Scholar
  4. Baldi, A., Ioannis, P., Chiara, P., Eleonora, F., Roubini, C., & Vittorio, D. (2005). Biological effects of milk proteins and their peptides with emphasis on those related to the gastrointestinal ecosystem. Journal of Dairy Research, 72, 66–72.CrossRefGoogle Scholar
  5. Bryan, D. L., Forsyth, K. D., Gibson, R. A., & Hawkes, J. S. (2006). Interleukin-2 in human milk: A potential modulator of lymphocyte development in the breastfed infant. Cytokine, 33, 289–293.CrossRefGoogle Scholar
  6. Chronopoulou, R., Xylouri, E., Fegeros, K., & Politis, I. (2006). The effect of two bovine β-casein peptides on various functional properties of porcine macrophages and neutrophils: Differential roles of protein kinase A and exchange protein directly activated by cyclic AMP-1. British Journal of Nutrition, 96, 553–561.Google Scholar
  7. Clare, D. A., & Swaisgood, H. E. (2000). Bioactive milk peptides: A prospectus. Journal of Dairy Science, 83, 1187–1195.Google Scholar
  8. de Moreno de LeBlanc, A., Matar, C., Theriault, C., & Perdigon, G. (2005). Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology, 210, 349–358.CrossRefGoogle Scholar
  9. de Moreno de LeBlanc, A., Matar, C., Farnworth, E., & Perdigon, G. (2006). Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir. Cytokine, 34, 1–8.CrossRefGoogle Scholar
  10. Dent, G., Giembycz, M. A., Rabe, K. F., Wolf, B., Barnes, P. J., & Magnussen, H. (1994). Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition. American Journal of Respiratory Cell and Molecular Biology, 10, 565–572.Google Scholar
  11. Fragou, S., Fegeros, K., Xylouri, E., Baldi, A., & Politis, I. (2004). Effect of vitamin E supplementation on various functional properties of macrophages and neutrophils obtained from weaned piglets. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine, 51, 1–6.Google Scholar
  12. Gill, H. S., Doull, F., Rutherfurd, K. J., & Cross, M. L. (2000). Immunoregulatory peptides in bovine milk. British Journal of Nutrition, 84, S111–S117.Google Scholar
  13. Kapsokefalou, M., Alexandropoulou, I., Komaitis, M., & Politis, I. (2005). In vitro evaluation of iron solubility and dialyzability of various iron fortificants and of iron-fortified milk products targeted for infants and toddlers. International Journal of Food Sciences and Nutrition, 56, 293–302.CrossRefGoogle Scholar
  14. Kelleher, S. L., & Lonnerdal, B. (2001). Immunological activities associated with milk. Advances in Nutritional Research, 10, 39–65.Google Scholar
  15. LeBlanc, J. G., Matar, C., Valdez, J. C., LeBlanc, J., & Perdigon, G. (2002). Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. Journal of Dairy Science, 85, 2733–2742.CrossRefGoogle Scholar
  16. Matar, C., Valdez, J. C., Medina, M., Rachid, M., & Perdigon, G. (2001). Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. Journal of Dairy Research, 68, 601–609.CrossRefGoogle Scholar
  17. Olivares, M., Diaz-Ropero, M. P., Gomez, N., Lara-Villoslada, F., Sierra, S., Maldonado, J. A., Martin, R., Rodriguez, J. M., & Xaus, J. (2006). The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. International Microbiology, 9, 47–52.Google Scholar
  18. Pecquet, S., Bovetto, L., Maynard, F., & Fritsche, R. (2001). Peptides obtained by tryptic hydrolysis of bovine β-lactoglobulin induce specific oral tolerance in mice. Journal of Allergy and Clinical Immunology, 105, 514–521.CrossRefGoogle Scholar
  19. Pessi, T., Isolauri, E., Sutas, Y., Kankaanranta, H., Moilanen, E., & Hurme, M. (2001). Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein. International Immunopharmacology, 1, 211–218.CrossRefGoogle Scholar
  20. Prioult, G., Pecquet, S., & Fliss, I. (2004). Stimulation of interleukin-10 production by acidic β-lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases. Clinical and Diagnostic Laboratory Immunology, 11, 266–271.CrossRefGoogle Scholar
  21. Rachid, M., Matar, C., Duarte, J., & Perdigon, G. (2006). Effect of milk fermented with a Lactobacillus helveticus R389(+) proteolytic strain on the immune system and on the growth of 4T1 breast cancer cells in mice. FEMS Immunology and Medical Microbiology, 47, 242–253.CrossRefGoogle Scholar
  22. Rowe, J., Finlay-Jones, J. J., Nicholas, T. E., Bowden, J., Morton, S., & Hart, P. H. (1997). Inability of histamine to regulate TNF-α production by human alveolar macrophages. American Journal of Respiratory Cell and Molecular Biology, 17, 218–223.Google Scholar
  23. Vinderola, C. G., Duarte, J., Thangavel, D., Perdigon, G., Farnworth, E., & Matar, C. (2005). Immunomodulating capacity of kefir. Journal of Dairy Research, 72, 195–202.CrossRefGoogle Scholar
  24. Vinderola, C. G., Perdigon, G., Duarte, J., Farnworth, E., & Matar, C. (2006). Effects of the oral administration of the products derived from milk fermentation by kefir microflora on immune stimulation. Journal of Dairy Research, 73, 472–479.CrossRefGoogle Scholar
  25. Wattrang, E., Wallgren, P., Lindberg, A., & Fossum, C. (1998). Signs of infections and reduced immune functions at weaning of conventionally reared and specific pathogen free pigs. Zentralblatt für Veterinärmedizin. Reihe B, 45, 7–17.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Ioannis Politis
    • 1
  • Roubini Chronopoulou
  1. 1.Department of Animal ScienceAgricultural University of AthensGreece

Personalised recommendations